Clinical Trial Update: Broad Effectiveness: Study With Aripiprazole [Phase 3]

View source ↗

Summary

Phase 3 study evaluating aripiprazole investigates overall effectiveness in schizophrenia and schizoaffective disorder; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Abilify (aripiprazole)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 3 | Status: COMPLETED